Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 14 open reading frame 2 pseudogene (ENSG00000233737) is classified as a pseudogene, meaning it is a DNA sequence that closely resembles a functional gene but has lost its ability to produce a protein product due to accumulated mutations or other genetic changes. Pseudogenes such as this one are typically nonfunctional, though occasionally pseudogenes can exert gene regulatory effects via RNA-based mechanisms or participate in gene expression modulation. However, no direct protein product, biological function, disease link, or therapeutic targeting or drug interaction is currently established for this specific pseudogene. This entry does not represent a classical therapeutic target (e.g., receptor, enzyme, transporter). It is mainly a nonfunctional genomic element annotated for completeness in the human genome. There is no evidence of protein expression or disease association, and thus it should not be considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 14 open reading frame 2 pseudogene (ENSG00000233737).